Vectus Biosystems Limited
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3
Ending by 2030
Dec 2026
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jun 5, 2027The maintenance fee for Compositions for the treatment of hypertension and/or fibrosis (US 11,834,417) comes due Jun 5, 2027. Unpaid by Dec 6, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,916,523 | Vip Fragments and Methods of Use In force · Low confidence | In force | Low confidence | |
| US 9,340,583 | VIP fragments and methods of use In force · From the USPTO record | In force | From the USPTO record | |
| US 7,951,777 | Compositions and methods for treatment of cardiovascular disease In force · From the USPTO record | In force | From the USPTO record | |
| US 9,458,093 | Compositions for the treatment of hypertension and/or fibrosis In force · From the USPTO record | In force | From the USPTO record | |
| US 9,630,935 | Compositions for the treatment of hypertension and/or fibrosis In force · From the USPTO record | In force | From the USPTO record | |
| US 10,035,775 | Compositions for the treatment of fibrosis and fibrosis-related conditions In force · From the USPTO record | In force | From the USPTO record | |
| US 10,183,908 | Compositions for the Treatment of Kidney And/Or Liver Disease In force · High confidence | In force | High confidence | |
| US 10,752,578 | Synthesis of terphenyl compounds In force · From the USPTO record | In force | From the USPTO record | |
| US 11,401,235 | Synthesis of terphenyl compounds In force · From the USPTO record | In force | From the USPTO record | |
| US 10,919,863 | Compositions for the treatment of pulmonary fibrosis In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 13: 2 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
Every application published under this name has become a patent.